Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with previously treated, recurrent or refractory ovarian cancer: A phase Ib, open-label expansion trial.
暂无分享，去创建一个
K. Kelly | G. Weiss | J. Infante | A. Heydebreck | A. Lockhart | Matthew H Taylor | J. Gulley | M. Gordon | M. Disis | S. Ejadi | K. Chin | J. Beck | S. Pant | J. Cuillerot | M. Patel | A. V. Heydebreck | Matthew H. Taylor | Manish R. Patel | Michael S. Gordon | Anja von Heydebreck | J. T. Beck | Jeffrey R. Infante | A. Craig Lockhart | Glen J. Weiss | Matthew Hiram Taylor